IMEXF (Imagin Medical) Effective Interest Rate on Debt %: 0.04% (As of Jun. 2023)


What is Imagin Medical Effective Interest Rate on Debt %?

Imagin Medical IMEXF -99.00% Effective Interest Rate on Debt % is 0.04% as of Jun. 2023.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Imagin Medical's annualized positive value of Interest Expense for the quarter that ended in Jun. 2023 was $0.00 Mil. Imagin Medical's average total debt for the quarter that ended in Jun. 2023 was $9.10 Mil. Therefore, Imagin Medical's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 was 0.04%.


Imagin Medical  (OTCPK:IMEXF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Imagin Medical Effective Interest Rate on Debt % Related Terms


Imagin Medical Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Imagin Medical's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical Effective Interest Rate on Debt % Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.64 0.00 0.00 0.06 0.06

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.05 0.04 0.04 0.04

IMEXF vs ABT, SYK, MDT: Effective Interest Rate on Debt % Comparison

For the Medical Devices subindustry, Imagin Medical's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imagin Medical Effective Interest Rate on Debt % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imagin Medical's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Imagin Medical's Effective Interest Rate on Debt % falls into.



Imagin Medical Effective Interest Rate on Debt % Calculation

Imagin Medical's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Sep. 2022 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Sep. 2021 )+Total Debt  (A: Sep. 2022 ))/ count )
=-1  *  -0.006/( (9.25+10.088)/ 2 )
=-1  *  -0.006/9.669
=0.06 %

where

Total Debt  (A: Sep. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 10.088
=10.088

Imagin Medical's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Mar. 2023 )+Total Debt  (Q: Jun. 2023 ))/ count )
=-1  *  -0.004/( (9.903+8.305)/ 2 )
=-1  *  -0.004/9.104
=0.04 %

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jun. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 0.04% mean?
Imagin Medical (IMEXF) has a Effective Interest Rate on Debt % of 0.04% as of Jun. 2023. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Imagin Medical and its competitors.
Is Imagin Medical's Effective Interest Rate on Debt % too high?
Imagin Medical's current Effective Interest Rate on Debt % is 0.04%.
How does Imagin Medical's Effective Interest Rate on Debt % compare to ABT and SYK?
Imagin Medical's Effective Interest Rate on Debt % of 0.04% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Medical Devices & Instruments company?
A good Effective Interest Rate on Debt % depends on the Medical Devices & Instruments industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Imagin Medical and its competitors. Imagin Medical's current Effective Interest Rate on Debt % is 0.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagin Medical stock overvalued right now?
Imagin Medical (IMEXF) has a current Effective Interest Rate on Debt % of 0.04%. The current Effective Interest Rate on Debt % is 0.04%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Imagin Medical (IMEXF), the current Effective Interest Rate on Debt % is 0.04% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.